Chemiesynth (Vapi) Ltd

Chemiesynth (Vapi) Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI regulations and the company's internal code of conduct. The trading window will be shut from July 01, 2026, and will reopen 48 hours after the announcement of the un-audited financial results for the quarter ending June 30, 2026. A board meeting to approve these financial statements is scheduled on or before August 14, 2026. All designated persons and their immediate relatives are prohibited from trading during this period.

Chemiesynth (Vapi) Ltd's board meeting on May 27, 2026, approved the audited financial results for the quarter and year ended March 31, 2026. The statutory auditors, M/s Manoj Shah & Co., issued an audit report with an unmodified opinion on the financial results. The meeting commenced at 3:00 PM and concluded at 4:45 PM.

Chemiesynth (Vapi) Ltd has scheduled a Board of Directors meeting on May 27, 2026, to consider and approve the audited financial results for the quarter and year ended March 31, 2026. The meeting will also address any other business items with the permission of the Chair and Majority of Directors. The trading window, which was closed from April 1, 2026, will reopen 48 hours after the declaration of results. The results will be available on the company website and published in newspapers.

Chemiesynth (Vapi) Ltd has announced the appointment of M/s Purvi Gandhi & Associates, Chartered Accountant (Registration No. 145052W) as its Internal Auditor for the Financial Year 2025-26 & 2026-27. The appointment was approved at a Board of Directors meeting held on 25-03-2026. The remuneration for the Internal Auditor will be mutually agreed upon between the Internal Auditor and the Board of Directors.

Chemiesynth (Vapi) Ltd, with CIN L24110GJ1986PLC008634 and GST Reg no 24AAACC9688H1ZC, has appointed M/s Purvi Gandhi & Associates, Chartered Accountant (Registration No. 145052W) as its Internal Auditor for the financial years 2025-26 and 2026-27. The appointment was made at a Board Meeting held on Wednesday, 25th March 2026, at 11:00 A.M. at Plot No. 27, GIDC, Vapi, Dist. Valsad, Gujarat 396195. The remuneration for the Internal Auditor will be mutually agreed upon between the Internal Auditor and the Board of Directors. The draft engagement letter specifying the scope, functioning, methodology, and remuneration was approved at the meeting.

Chemiesynth (Vapi) Ltd has announced the closure of the trading window for all directors, designated persons, connected person and immediate relatives. The closure is in compliance with the SEBI (Prohibition of Insider trading) Regulations, 2015 and the Company's Code of Internal Procedures and Conduct. The trading window will remain closed from Wednesday, April 01, 2026 until 48 hours after the announcement of the audited financial results for the quarter and financial year ended March 31, 2026. The board meeting for the approval of audited financial statements will be held on or before May 31, 2026. Designated persons and their immediate relatives are advised not to trade in the securities of the Company during this period.

Chemiesynth (Vapi) Ltd has announced the reconstitution of its Nomination and Remuneration Committee. The reconstitution was approved at a Board meeting held on 13-02-2026. The changes were made to ensure compliance with Section 178 of the Companies Act, 2013 and Regulation 19 of the SEBI (LODR) Regulations, 2015. Mr. Sandip Zaveri, Promoter Director, ceased to be a member and Mr. Satish Zaveri, Promoter Non-Executive Director, was appointed as a member. The reconstituted Committee comprises Mr. Pramod G. Gujarathi, Mr. Jigna Prajapati, and Mr. Satish Zaveri.

Chemiesynth (Vapi) Ltd, a company involved in the manufacturing of chemicals, has reported its unaudited standalone financial results for the quarter and nine months ended December 31, 2025. The company's Board of Directors approved the financial results and the limited review report from the statutory auditor. The company also approved the reconstitution of the Nomination & Remuneration Committee.

Chemiesynth (Vapi) Ltd has approved the unaudited standalone financial results for the quarter ended on 31st December 2025. The approval was given at the Board of Directors meeting held on 13th February 2025. The financial results were reviewed by the audit committee and approved by the Board. The statement has been prepared in accordance with the Companies (Indian Accounting Standards) Rules 2015 and the SEBI (Listing Obligation and Disclosure Requirement) Regulations 2015. The reports of the statutory auditor are unqualified.

Chemiesynth (Vapi) Ltd has announced that its Board of Directors will meet on February 13, 2026, to consider and approve the Standalone Unaudited Financial Results for the quarter ended on December 31, 2025. The meeting will also discuss any other items with the permission of the Chair and majority of Directors. In accordance with the SEBI (Prohibition of Insider Trading) Regulations, the trading window will be closed from January 01, 2026, and will open after 48 hours of the declaration of results. The results will be uploaded onto the company's website and published in newspapers.